Universal-Beteiligungs- und Servicegesellschaft’s Edwards Lifesciences EW Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$115M	Sell	1,433,495 -135,742	-9%	-$11.2M	0.2%	96
2025 Q4	$134M	Buy	1,569,237 +21,165	+1%	+$1.74M	0.22%	88
2025 Q3	$120M	Buy	1,548,072 +63,850	+4%	+$4.99M	0.2%	99
2025 Q2	$116M	Buy	1,484,222 +89,122	+6%	+$6.65M	0.21%	94
2025 Q1	$101M	Buy	1,395,100 +143,841	+11%	+$10.3M	0.2%	103
2024 Q4	$92.6M	Buy	+1,251,259	New	+$87.6M	0.18%	117

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's EW Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Edwards Lifesciences (EW) stake by 8.7% in Q1 2026, selling an estimated $11.2M and leaving 1,433,495 shares worth $115M. The position accounts for 0.2% of the portfolio, ranked #96.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $134M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Universal-Beteiligungs- und Servicegesellschaft held 1,433,495 shares of Edwards Lifesciences worth $115M as of Q1 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 135,742 Edwards Lifesciences shares in Q1 2026, an estimated $11.2M.
Edwards Lifesciences made up 0.2% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #96 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's Edwards Lifesciences position peaked at $134M in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.